| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fennec Pharmaceuticals Inc. (FENC) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. FENC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $18.58M | - | |
| CFO | 826.6K | $5.60M | - | |
| Dir | 225.0K | $1.52M | - | |
| Dir | 215.5K | $1.46M | - | |
| Dir | 174.3K | $1.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | Raykov Rosty55 | Chief Executive Officer | Sell | 40,584 | $10.78 | $437,451.07 | -6.6% | -44.0% | -48.1% | |
| Apr 1, 2024 | Andrade Robert69 | Chief Financial Officer | Buy | 12,500 | $0.00 | - | +13.6% | -42.2% | -49.0% | |
| Apr 1, 2024 | Raykov Rosty55 | Chief Executive Officer | Buy | 29,167 | $0.00 | - | +10.1% | -42.2% | -49.0% | |
| Mar 26, 2024 | Andrade Robert69 | Chief Financial Officer | Sell | 13,975 | $10.90 | $152,345.67 | -13.2% | -41.7% | -40.6% | |
| Mar 26, 2024 | Rallis Chris A62 | Director | Sale+OE | 2,114 | $10.97 | $23,190.58 | -4.9% | -41.7% | -40.6% | |
| Mar 25, 2024 | Andrade Robert69 | Chief Financial Officer | Sell | 13,975 | $11.00 | $153,690.06 | -11.7% | -42.3% | -41.5% | |
| Jan 5, 2024 | Andrade Robert69 | Chief Financial Officer | Sell | 30,000 | $10.53 | $315,750.00 | -10.5% | +5.4% | -40.6% | |
| Dec 28, 2023 | Raykov Rosty55 | Chief Executive Officer | Sale+OE | 3,656 | $11.55 | $42,226.80 | -1.3% | -4.5% | -46.4% | |
| Dec 26, 2023 | Rallis Chris A62 | Director | Sale+OE | 1,390 | $10.90 | $15,151.00 | -3.0% | -5.2% | -45.1% | |
| Nov 20, 2023 | Rallis Chris A62 | Director | Sell | 269 | $8.25 | $2,219.25 | -0.6% | +3.3% | -49.9% |